CSPC Innovation Pharmaceutical Co., Ltd.
SZSE:300765.SZ
23.56 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| 755.557 | 726.612 | 316.544 | 299.712 | 273.528 | 224.323 | 194.911 | 206.355 | 115.485 | 108.235 |
| Depreciation & Amortization
| 100.097 | 72.944 | 51.374 | 53.417 | 47.138 | 43.032 | 35.257 | 27.001 | 25.312 | 21.097 |
| Deferred Income Tax
| 1.478 | -6.986 | -1.008 | 2.293 | -0.683 | -3.915 | -4.82 | 0.624 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 111.102 | -99.453 | -200.184 | 22.159 | 13.63 | -103.159 | -234.541 | -80.636 | -30.761 | -36.926 |
| Accounts Receivables
| 165.853 | -224.894 | -119.206 | 38.905 | -15.673 | -138.266 | -140.663 | -120.983 | 5.641 | 11.3 |
| Inventory
| 3.901 | -24.816 | -105.859 | 13.232 | 5.209 | -15.6 | -56.142 | -24.633 | -3.886 | -19.291 |
| Accounts Payables
| -58.653 | 157.243 | 56.706 | -32.271 | 24.776 | 54.621 | -32.916 | 64.357 | 0 | 0 |
| Other Working Capital
| 0 | -6.986 | -31.825 | 2.293 | -0.683 | -87.56 | -178.399 | -56.003 | -26.876 | -17.634 |
| Other Non Cash Items
| 48.1 | -59.385 | 2.858 | -26.217 | -18.911 | -4.468 | 5.673 | -15.454 | 2.013 | 0.955 |
| Operating Cash Flow
| 927.241 | 640.718 | 170.592 | 349.072 | 315.384 | 159.728 | 1.3 | 137.267 | 112.048 | 93.362 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -95.732 | -114.05 | -66.918 | -117.743 | -106.1 | -58.963 | -42.782 | -147.791 | -47.67 | -8.085 |
| Acquisitions Net
| 3.745 | 5.816 | 118.795 | 120.58 | 106.523 | 0.049 | 1.542 | 1.188 | 0 | 0 |
| Purchases Of Investments
| -1 | -910 | -1,360 | -2,496.05 | -2,423.449 | -10 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| -2.745 | 1,330.112 | 1,278.968 | 2,957.121 | 1,455.396 | 10.112 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 2.745 | -0 | 2.296 | -117.743 | -106.1 | 12.81 | -3.943 | 168.186 | -37.021 | -17.998 |
| Investing Cash Flow
| -92.986 | 311.878 | -26.86 | 346.166 | -1,073.729 | -45.991 | -46.725 | 20.394 | -84.692 | -26.084 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -20 | -20 | -0.864 | 0 | -70.158 | -43.935 | -120 | 0 | -120 | 0 |
| Common Stock Issued
| 488.166 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -4.248 | -0.069 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -97.562 | -97.562 | -42 | -28 | -1.498 | -3.391 | -24.841 | -53.241 | -1.753 | 0 |
| Other Financing Activities
| -1.15 | 39.067 | -0.864 | 0 | 1,146.473 | 19.101 | 109.62 | -138.699 | 21.091 | -6 |
| Financing Cash Flow
| 365.206 | -63.006 | -42.864 | -28 | 1,074.818 | -28.225 | -35.221 | -191.94 | 19.338 | -6 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 31.165 | 57.55 | -6.75 | -2.128 | 2.267 | 0.16 | -1.719 | 3.598 | 0.78 | -0.012 |
| Net Change In Cash
| 1,226.488 | 947.139 | 94.118 | 665.109 | 318.74 | 85.671 | -82.364 | -30.681 | 47.475 | 61.267 |
| Cash At End Of Period
| 3,422.173 | 2,191.546 | 1,231.863 | 1,137.745 | 472.636 | 153.896 | 68.225 | 150.589 | 181.269 | 133.794 |